Member Info for nomlungu

'he'll go down'... probably for 20 years which will be a life sentence for him.

And the time will have to be done in solitary because he is a security risk.

sectorbreakdown,

Trump just playing for time whilst he tries to steal the election; after the 5th of December the individual state congresses can decide who won the elections if no winner has been declared.

Constitutional games are afoot - you might still win your bet but only because the ref is corrupt.

Kenny

Section 230...

Kenny,

If it was on YouTube it must be true.

Xenu from the Galactic Confederacy also arranged millions of Biden votes - breaking news from Clearwater?

Proper reliable sources them Scientologists and Falun Gong

Pesky firewall - all I can read is

'Hargreaves Lansdown platform failure pushes investors into debt'

Does not sound good

pesky foreigners

Not only are they scientists but foreigners as well, and the drugs will be tested in Holland.

Rabid Brexiteers will probably go full antivac

Surely 50p would have been better as there was a 100 to 1 consolidation after 2p?

Worth a read

https://www.biopharmadive.com/news/pfizer-biontech-coronvirus-vaccine-details-safety/588733/

A long way to go still

'It's also unclear from the companies' announcement whether the shot is equally protective against mild and more severe COVID-19, or whether vaccination protected against infection as well as disease.

If the vaccine can't block transmission of the virus, prevention guidelines like wearing masks or social distancing will remain critical even after inoculation.'

Transfer - not a cash transaction, was it?

Some are moaning that they tried selling / buying shares on that platform and got no response so tried again and again and again. In the end all transaction requests were processed and some accounts now showing negative share balances / negative cash balances.

They are going to have fun sorting that nonsense out...

Might have to lay off roadkill this year in case the carcasses are infected...

Troajan,

No data has been released for peer review yet. Unknowns:

Does it prevent only mild Covid or does it prevent serious Covid infections as well?
Does it protect the most vulnerable [old or underlying illness]?
I approved, will there be sufficient uptake to end transmission?
Will poor countries be able to distribute the vaccine if it requires a specialised cold chain?
Will it work across ethnicities [different DNA]?
How long will immunity last?
Will it be effective against mutations of the virus?
Will adverse reactions happen many months after taking the vaccine [vaccine induced disease exacerbation]?
Will the virus mutate into a more potent pathogen after exposure to the virus?

2 other points; Pfizer will only be able to manufacture enough of the vaccine for 650m people by the end of next year. And, no mRNA vaccine has ever been approved for human use [yet]. The game is far from over but some of the runners and riders are starting to fall away.

mrcautious,

The annual accounts are likely to be out soon and I expect that the NAV will be over double the current share price. That alone should give the share price a boost. I am also expecting some [positive] forward-looking statements about drilling at LS and progress on the gold assets bought into a while ago.

I have been hoping that the buy price would drop below 7p before the accounts come out; it is looking unlikely but I will be tempted to buy a few more if the bargain was to be offered.

Some people got burnt today; might be an interesting week.

Some people got burnt today; might be an interesting week.

Got to be stored at -80%C; I had a look a while ago and could not find a listed fridge manufacturer / distributor who would benefit from the expected significant spike in sales of specialist freezers.

BBC saying they have announced 90% effectiveness

https://www.theguardian.com/world/2020/nov/09/covid-19-vaccine-candidate-effective-pfizer-biontech

Market going to get a sugar rush to highs?

Another step in the right direction; authorisation, distribution and sales in the US will help drive sales in other markets and in due course provide more data from larger acreages.

No interest from the market though [as usual] even though this may be a notable step towards the generation of significant free cash flow.